EscharEx has demonstrated a favorable safety profile and effective wound bed preparation in multiple Phase II trials. The therapy has shown the ability to remove non-viable tissue, promote ...

“NexoBrid provides a rapid, non-surgical solution that effectively removes eschar while preserving healthy tissue, addressing the critical need to protect viable dermis and improve outcomes for ...

Presentations at WHS and SAWC to highlight EscharEx's mechanism of action, preclinical advantages over SANTYL®, and new data in treating V ...